Cargando…
Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trial
ABSTRACT: Iota-carrageenan (I-C) is active against respiratory viruses in vitro and was effective as nasal spray in three previous clinical trials. The current trial served to further investigate I-C in patients with early common cold symptoms. METHODS: This randomized, placebo-controlled, double-bl...
Autores principales: | Eccles, R., Winther, B., Johnston, S.L., Robinson, P., Trampisch, M., Koelsch, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595062/ https://www.ncbi.nlm.nih.gov/pubmed/26438038 http://dx.doi.org/10.1186/s12931-015-0281-8 |
Ejemplares similares
-
Safety and efficacy of iota-carrageenan nasal spray in treatment and prevention of the common cold
por: Bichiri, Diana, et al.
Publicado: (2021) -
Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold
por: Eccles, Ron, et al.
Publicado: (2010) -
Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold
por: Fazekas, Tamas, et al.
Publicado: (2012) -
Development of a nasal spray containing xylometazoline hydrochloride and iota-carrageenan for the symptomatic relief of nasal congestion caused by rhinitis and sinusitis
por: Graf, Christine, et al.
Publicado: (2018) -
Low Acyl Gellan as an Excipient to Improve the Sprayability and Mucoadhesion of Iota Carrageenan in a Nasal Spray to Prevent Infection With SARS-CoV-2
por: Robinson, Thomas E., et al.
Publicado: (2021)